
    
      Subjects will be randomized into one of three groups. One group will receive a placebo
      vaccine and the other two will receive different dengue vaccine formations. Each subject will
      receive two doses six months apart. All subjects will have 11 venipunctures during 11 visits
      (i.e., screening plus 10 study visits) over a period of nine months.
    
  